These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4956868)

  • 1. TRIC (trachoma-inclusion conjunctivitis) agents and interferon.
    Mordhorst CH; Reinicke V
    Acta Pathol Microbiol Scand; 1965; 65(4):545-53. PubMed ID: 4956868
    [No Abstract]   [Full Text] [Related]  

  • 2. SEROLOGICAL STUDIES ON GROUP- AND SPECIES-SPECIFIC ANTIGENS OF TRACHOMA AND INCLUSION CONJUNCTIVITIS (TRIC) AGENTS.
    TERZIN AL; VEDROS NA; JOHNSTON JB
    J Hyg (Lond); 1964 Jun; 62(2):185-98. PubMed ID: 14171270
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemagglutination by the TRIC group of Chlamydia.
    Elvin-Lewis PF; Czekalowski JW
    J Med Microbiol; 1971 Feb; 4(1):31-41. PubMed ID: 5548601
    [No Abstract]   [Full Text] [Related]  

  • 4. Virulence and host specificity of TRIC agents.
    Moore JE; Griffiths MS; Pearce JH
    J Gen Microbiol; 1969 Dec; 59(3):iv-v. PubMed ID: 4984857
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to TRIC agents in matched human tears and sera.
    Hanna L; Jawetz E; Briones O; Ostler HB; Keshishyan H; Dawson CR
    J Immunol; 1973 Jun; 110(6):1464-9. PubMed ID: 4576502
    [No Abstract]   [Full Text] [Related]  

  • 6. [The complement-fixation test in TRIC agents' diagnosis].
    Nabli B
    Rev Int Trach; 1973; 50(3):39-62. PubMed ID: 4780352
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to TRIC agents in tears and serum of naturally infected humans.
    Hanna L; Jawetz E; Briones OC; Keshishyan H; Hoshiwara I; Ostler HB; Dawson CR
    J Infect Dis; 1973 Jan; 127(1):95-8. PubMed ID: 4566623
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. II. Experiments with a 'slow-killing' strain.
    Collier LH; Mogg AE
    J Hyg (Lond); 1969 Sep; 67(3):449-55. PubMed ID: 4980360
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIC VIRUSES: AGENTS OF TRACHOMA AND INCLUSION CONJUNCTIVITIS.
    JAWETZ E; THYGESON P
    Ergeb Mikrobiol Immunitatsforsch Exp Ther; 1964; 38():55-95. PubMed ID: 14269512
    [No Abstract]   [Full Text] [Related]  

  • 10. GROWTH IN THE CHICK EMBRYO OF STRAINS OF TRACHOMA AND INCLUSION BLENNORRHOEA VIRUS OF DIFFERING VIRULENCE.
    TAVERNE J; BLYTH WA; REEVE P
    J Gen Microbiol; 1964 Nov; 37():277-84. PubMed ID: 14252294
    [No Abstract]   [Full Text] [Related]  

  • 11. [CYTOLYTIC EFFECT OF THE TRACHOMA AGENT AND THE AGENT OF INCLUSION CONJUNCTIVITIS ON HUMAN EMBRYONAL FIBROBLAST CULTURES].
    LASSALLE J
    C R Hebd Seances Acad Sci; 1963 Oct; 257():2562-4. PubMed ID: 14093977
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity of human antibodies to TRIC agents (chlamydiae) detected by different serologic procedures.
    Isa AM; Hanna L; Jawetz E
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1087-92. PubMed ID: 4888742
    [No Abstract]   [Full Text] [Related]  

  • 13. [STUDIES ON TRACHOMA. 9. NEW EXPERIMENTAL INOCULATIONS OF VOLUNTEERS WITH TRACHMONA AND INCLUSION CONJUNCTIVITIS VIRUS].
    TARIZZO ML; NATAF R; NABLI B
    Bull World Health Organ; 1964; 30(5):675-91. PubMed ID: 14198747
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance.
    Jawetz E; Rose L; Hanna L; Thygeson P
    JAMA; 1965 Nov; 194(6):620-32. PubMed ID: 5319187
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of TRIC agents by virus-induced interferon.
    Hanna L; Merigan TC; Jawetz E
    Proc Soc Exp Biol Med; 1966 Jun; 122(2):417-21. PubMed ID: 5980548
    [No Abstract]   [Full Text] [Related]  

  • 16. GUINEA PIG INCLUSION CONJUNCTIVITIS VIRUS. I. ISOLATION AND IDENTIFICATION AS A MEMBER OF THE PSITTACOSIS-LYMPHOGRANULOMA-TRACHOMA GROUP.
    MURRAY ES
    J Infect Dis; 1964 Feb; 114():1-12. PubMed ID: 14118043
    [No Abstract]   [Full Text] [Related]  

  • 17. TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENTS: ADAPTATION TO HELA CELL CULTURES.
    MITSUI Y; KITAMURO T; ENDO K; MATSUMURA K
    Science; 1964 Aug; 145(3633):715-6. PubMed ID: 14163803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRACHOMA VIRUSES ISOLATED IN THE UNITED STATES. VI. CROSS-IMMUNIZATION STUDIES IN CYNOMOLGUS MONKEYS WITH STRAINS OF TRACHOMA AND INCLUSION CONJUNCTIVITIS VIRUSES.
    MORDHORST CH
    Am J Ophthalmol; 1963 Sep; 56():395-403. PubMed ID: 14064885
    [No Abstract]   [Full Text] [Related]  

  • 19. BEHAVIOUR IN EGGS AND TISSUE CULTURE OF THE INCLUSION BLENNORRHOEA (LB4) STRAIN OF THE TRACHOMA-INCLUSION CONJUNCTIVITIS VIRUS GROUP.
    LARIN NM; TREHARNE JD
    Nature; 1964 Oct; 204():166-7. PubMed ID: 14222264
    [No Abstract]   [Full Text] [Related]  

  • 20. ISOLATION OF THE TRIC AGENT FROM EYE AND UROGENITAL TRACT OF TRACHOMA PATIENTS IN DENMARK.
    MORDHORST CH
    Acta Pathol Microbiol Scand; 1965; 63():637-8. PubMed ID: 14330311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.